Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT
- Conditions
- Re-entrant Atrioventricular TachycardiaTachycardia, Atrioventricular Nodal Reentry
- Interventions
- Procedure: RFA
- Registration Number
- NCT01594814
- Lead Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Brief Summary
Atrioventricular nodal reciprocating tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT) are two similar supraventricular re-entry tachycardias (SVT) emerging in relatively young age in patients without apparent structural heart disease or significant comorbidities. The treatment of choice in those patients is radiofrequency ablation (RFA).
The PPRA study is a prospective observational study developed to thoroughly analyze quality of life, utility and willingness-to-pay of Polish patients undergoing RF ablation of AVNRT or AVRT.
Based on collected data the investigators will prepare a profile of patient who will benefit most from radiofrequency ablation and who should be scheduled in first place for the ablation in case of problems with accessibility to this service.
What is more an analysis of medical and indirect costs of care will be performed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 82
- Written informed consent
- Age above 18
- Scheduled RFA due to AVNRT or AVRT
- Sufficient knowledge of the Polish language to independently complete the questionnaires
- No written informed consent
- Health states significantly impairing QoL (eg. stroke, advanced heart failure)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description RFA of AVNRT of AVRT RFA -
- Primary Outcome Measures
Name Time Method Health-related quality of life (HRQOL) two months Mean score of Patient Perception of Arrhythmia Questionnaire (PPAQ) - a disease-specific QoL questionnaire for patients suffering from supraventricular tachycardia translated and validated according to ISPOR (International Society For Pharmacoeconomics and Outcomes Research) guidelines
- Secondary Outcome Measures
Name Time Method Effectiveness two days Data on medical history, final diagnosis, outcome of treatment, safety and future recommendations
Utility of health state two months Mean score of EQ-5D - a generic questionnaire measuring a health state utility (official Polish translation)
Medical and indirect cost one year Cross-sectional data gathered using original questionnaire designed to measure medical and indiresct costs related to arrhythmia incurred during a year preceding RFA
Willingness-to-pay one day a cross-sectional willingness-to-pay questionnaire studying hypothetical situation where RFA was not financed by Polish Health Fund
Trial Locations
- Locations (1)
Institute of Cardiology, II Dept. of Coronary Heart Disease
🇵🇱Warsaw, Poland